Skip to main content

Pfizer Pfizer CentreOne revenue

  • PFE · NYSE
  • Pharmaceuticals
  • S&P 500
$28.89+0.21%Close 13 Nov 2026 · Market value $164.8B

Pfizer CentreOne revenue at Pfizer came to $300.0M for the quarter to 27 Sep 2026, down 12.8% from a year earlier.

As Pfizer reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$258.0MMar 2024$278.0MJun 2024$285.0MSep 2024$326.0MDec 2024$273.0MMar 2025$348.0MJun 2025$344.0MSep 2025$372.0MDec 2025$289.0MMar 2026$373.0MJun 2026$300.0MSep 2026
Pfizer Pfizer CentreOne revenue, every reported period
Period endingPfizer CentreOne revenueChange on a yearFiled
27 Sep 2026$300.0Mdown 12.8%3 Nov 2026
28 Jun 2026$373.0Mup 7.2%4 Aug 2026
29 Mar 2026$289.0Mup 5.9%5 May 2026
31 Dec 2025$372.0Mup 14.1%26 Feb 2026
28 Sep 2025$344.0Mup 20.7%4 Nov 2025
29 Jun 2025$348.0Mup 25.2%5 Aug 2025
30 Mar 2025$273.0Mup 5.8%5 May 2025
31 Dec 2024$326.0M—27 Feb 2025
29 Sep 2024$285.0M—4 Nov 2024
30 Jun 2024$278.0M—5 Aug 2024
31 Mar 2024$258.0M—8 May 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Pfizer: Product revenue · Royalty revenue · Biopharma revenue · Business Innovation Segment revenue · United States revenue · International Developed Markets revenue · International Emerging Markets revenue · financial statements

Every KPI and segment of PFE, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.